What to do about orchestrated email campaigns: authors, editors, publishers, advertisers, and shareholders should ignore them.
| Published in: | BMJ: British Medical Journal (Overseas & Retired Doctors Edition) pp. 491 - 493 |
|---|---|
| Main Authors: | , |
| Format: | editorial Journal Article |
| Published: |
BMJ Publishing Group
2/28/2009
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105481612&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105481612 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17592151 BLM8 jtl: BMJ: British Medical Journal (Overseas & Retired Doctors Edition) issn: 17592151 maglogo: N pubinfo: dt: 2/28/2009 pid: 8280 pub: BMJ Publishing Group artinfo: ui: 105481612 105481612 2010227426 105481612 ppf: 491 ppct: 2 formats: tig: atl: What to do about orchestrated email campaigns: authors, editors, publishers, advertisers, and shareholders should ignore them. aug: au: Delamothe D Godlee F sug: subj: Email Evaluation Politics United Kingdom pubtype: Academic Journal doctype: editorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|